Clinical Trials Logo
  1. Home
  2. Schizophrenia
  3. NCT00597168
  4. Details
NCT00597168 Clinical Trial

Quality of Life in Schizophrenic Patients

Schizophrenia Clinical Trial

— Quality  

Official title:
QUALITY: A Non-interventional Study Evaluating Quality Of Life in Schizophrenic Patients Treated With Atypical Antipsychotics, in the Ambulatory Setting. A 9-month, Observational, Multicentric Prospective Study.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00597168
Other study ID # NIS-NBE-SER-2006/1
Secondary ID
Status Completed
Phase N/A
First received November 28, 2007
Last updated June 8, 2010
Start date October 2007
Est. completion date October 2009

Study information
Verified date June 2010
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Belgium: Institutional Review Board
Study type Observational

Clinical Trial Summary

This is a non-interventional study evaluating quality of life in schizophrenic patients treated with atypical antipsychotics, in the ambulatory setting. This is a 9-month, observational, multicentric prospective study.

Recruitment information / eligibility
Status Completed
Enrollment 124
Est. completion date October 2009
Est. primary completion date October 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients diagnosed with Schizophrenia treated with atypical antipsychotics (ambulatory patients).

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Belgium Research Site Aalst
Belgium Research Site Asse
Belgium Research Site Bertrix
Belgium Research Site Bierbeek
Belgium Research Site Boechout
Belgium Research Site Bon-secours
Belgium Research Site Bruxelles
Belgium Research Site Dendermonde
Belgium Research Site Diest
Belgium Research Site Duffel
Belgium Research Site Eeklo
Belgium Research Site Elsene
Belgium Research Site Embourg
Belgium Research Site Floreffe
Belgium Research Site Gent
Belgium Research Site Halle
Belgium Research Site Henri-Chapelle
Belgium Research Site Herstal
Belgium Research Site Jambes
Belgium Research Site Kortenberg
Belgium Research Site Kortrijk
Belgium Research Site La Louviere
Belgium Research Site Leut
Belgium Research Site Leuven
Belgium Research Site Libramont
Belgium Research Site Liege
Belgium Research Site Lierneux
Belgium Research Site Melle
Belgium Research Site Menen
Belgium Research Site Mol
Belgium Research Site Mons
Belgium Research Site Oostende
Belgium Research Site Ottignies
Belgium Research Site Roeselare
Belgium Research Site Schaerbeek
Belgium Research Site Sint-Kruis (Brugge)
Belgium Research Site Sint-Lambrechts-Woluwe
Belgium Research Site Sint-Michiels
Belgium Research Site Sint-Niklaas
Belgium Research Site Sint-Truiden
Belgium Research Site Sleidinge
Belgium Research Site Tielt
Belgium Research Site Tienen
Belgium Research Site Veurne
Belgium Research Site Waregem
Belgium Research Site Woluwe-Saint-Lambert

Sponsors (1)
Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Belgium, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change from baseline of QOL assessed by the SWN-K after 9 months of treatment with AAPs. 9 months
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A